carnitine has been researched along with Idiopathic Parkinson Disease in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is thought that Parkinson's disease is caused by the accumulation of abnormally folded alpha-synuclein protein, accompanied by persistent neuroinflammation, oxidative stress, and subsequent neuronal injury/death." | 1.48 | l-Carnitine Inhibits Lipopolysaccharide-Induced Nitric Oxide Production of SIM-A9 Microglia Cells. ( Garrett, TJ; Gill, EL; Raman, S; Vedam-Mai, V; Yost, RA, 2018) |
| "The plasma analyses identified 18 Parkinson's disease-specific metabolites and revealed decreased levels of seven long-chain acylcarnitines in two Parkinson's disease cohorts (n = 109, 145) compared with controls (n = 32, 45), respectively." | 1.46 | Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease. ( Amo, T; Fujimaki, M; Fukuhara, T; Furuya, N; Hatano, T; Hattori, N; Imamichi, Y; Ishikawa, KI; Koinuma, T; Mori, A; Nagumo, M; Nojiri, S; Oji, Y; Okuzumi, A; Saiki, S; Yamashiro, K, 2017) |
| "Two groups of 10 patients with Parkinson's disease received doses of either 1g acetyl-L-carnitine (ALC) per day for seven days or 2g." | 1.28 | Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease. ( Brancasi, B; D'Ursi, R; Genco, S; Martino, R; Miccoli, A; Prudenzano, A; Puca, FM; Savarese, M; Scarcia, R; Specchio, LM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Albillos, SM | 1 |
| Montero, O | 1 |
| Calvo, S | 1 |
| Solano-Vila, B | 1 |
| Trejo, JM | 1 |
| Cubo, E | 1 |
| Chai, JF | 1 |
| Raichur, S | 1 |
| Khor, IW | 1 |
| Torta, F | 1 |
| Chew, WS | 1 |
| Herr, DR | 1 |
| Ching, J | 1 |
| Kovalik, JP | 1 |
| Khoo, CM | 1 |
| Wenk, MR | 1 |
| Tai, ES | 1 |
| Sim, X | 1 |
| Molsberry, S | 1 |
| Bjornevik, K | 1 |
| Hughes, KC | 1 |
| Zhang, ZJ | 1 |
| Jeanfavre, S | 1 |
| Clish, C | 1 |
| Healy, B | 1 |
| Schwarzschild, M | 1 |
| Ascherio, A | 1 |
| Sinclair, E | 1 |
| Trivedi, DK | 1 |
| Sarkar, D | 1 |
| Walton-Doyle, C | 1 |
| Milne, J | 1 |
| Kunath, T | 1 |
| Rijs, AM | 1 |
| de Bie, RMA | 1 |
| Goodacre, R | 1 |
| Silverdale, M | 1 |
| Barran, P | 1 |
| Saiki, S | 2 |
| Hatano, T | 2 |
| Fujimaki, M | 2 |
| Ishikawa, KI | 2 |
| Mori, A | 1 |
| Oji, Y | 1 |
| Okuzumi, A | 1 |
| Fukuhara, T | 1 |
| Koinuma, T | 1 |
| Imamichi, Y | 1 |
| Nagumo, M | 1 |
| Furuya, N | 1 |
| Nojiri, S | 2 |
| Amo, T | 1 |
| Yamashiro, K | 1 |
| Hattori, N | 2 |
| Gill, EL | 1 |
| Raman, S | 1 |
| Yost, RA | 1 |
| Garrett, TJ | 1 |
| Vedam-Mai, V | 1 |
| Crooks, SA | 1 |
| Bech, S | 1 |
| Halling, J | 1 |
| Christiansen, DH | 1 |
| Ritz, B | 1 |
| Petersen, MS | 1 |
| Ueno, SI | 1 |
| Takeshige-Amano, H | 1 |
| Oyama, G | 1 |
| Yamaguchi, A | 1 |
| Akamatsu, W | 1 |
| Irwin, MH | 1 |
| Moos, WH | 1 |
| Faller, DV | 1 |
| Steliou, K | 1 |
| Pinkert, CA | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Rubio, JC | 1 |
| Molina, JA | 1 |
| Martín, MA | 1 |
| Campos, Y | 1 |
| Benito-León, J | 1 |
| Ortí-Pareja, M | 1 |
| Gasalla, T | 1 |
| Arenas, J | 1 |
| Puca, FM | 1 |
| Genco, S | 1 |
| Specchio, LM | 1 |
| Brancasi, B | 1 |
| D'Ursi, R | 1 |
| Prudenzano, A | 1 |
| Miccoli, A | 1 |
| Scarcia, R | 1 |
| Martino, R | 1 |
| Savarese, M | 1 |
1 review available for carnitine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.
Topics: Alzheimer Disease; Antioxidants; Carnitine; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Hum | 2016 |
1 trial available for carnitine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Cerebrospinal fluid carnitine levels in patients with Parkinson's disease.
Topics: Acylation; Aged; Antiparkinson Agents; Carnitine; Female; Humans; Levodopa; Male; Middle Aged; Oxida | 1997 |
9 other studies available for carnitine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study.
Topics: Aged; Bilirubin; Biomarkers; Carnitine; Case-Control Studies; Cognition; Cortodoxone; Diagnosis, Dif | 2021 |
Associations with metabolites in Chinese suggest new metabolic roles in Alzheimer's and Parkinson's diseases.
Topics: Alzheimer Disease; Asian People; ATP-Binding Cassette Transporters; Carnitine; China; DNA-Binding Pr | 2020 |
Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.
Topics: Adult; Aged; Biomarkers; Carnitine; Diabetes Mellitus; Female; Humans; Insulin Resistance; Male; Met | 2020 |
Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease.
Topics: Aged; Arachidonic Acid; Biomarkers; Carnitine; Chromatography, Liquid; Fatty Acids; Female; Humans; | 2021 |
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Topics: Aged; Biomarkers; Carnitine; Cohort Studies; Fatty Acids; Female; Humans; Male; Metabolome; Metabolo | 2017 |
l-Carnitine Inhibits Lipopolysaccharide-Induced Nitric Oxide Production of SIM-A9 Microglia Cells.
Topics: Animals; Carnitine; Cell Line; Dopaminergic Neurons; Lipopolysaccharides; Macrophages; Mice; Microgl | 2018 |
Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathies; Carnitine; Case-Control Studies; Denmark; Female; | 2018 |
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carnitine; Fatty Acids; Female; Humans; Levodopa; Mal | 2018 |
Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease.
Topics: Acetylcarnitine; Adult; Aged; Carnitine; Electroencephalography; Electromyography; Female; Humans; M | 1990 |